Our passions are the emerging biotechnology firm and relations between academic biomedical researchers and the private sector biomedical industry.

We feel that these emerging companies – unlike large pharmaceutical firms – can best utilize the services we offer, as there is a mutually-beneficial fit in terms of size, energy, philosophy and interest. The discoveries that originate from emerging firms will have the most significant clinical impact in the coming decades – particularly in the fields of immunology, oncology, infectious disease, neurology and genetic science.

Additionally, there is often a need for a facilitator (or catalyst) for the advancement of discoveries from the university laboratory (or clinical research unit) to the biomedical products industry. Can scientists learn to think more like business people? Can business people better appreciate the often-arcane language of biomedical science? We help serve as that essential translator.

The Viridis Group is dedicated to establishing and maintaining a close working relationship with our clients - from both academia and the private sector. We do not merely aim to meet their expectations…we exceed them. Customer satisfaction is simply not acceptable…we strive for client delight.

Unlike most large management consulting firms, The Viridis Group works only in biomedical R&D. Unlike most large management consulting firms, our services are provided at a reasonable and competitive cost, since we do not have to support such sizeable overhead. And unlike most large management consulting firms, your investment in us pays for itself multiple times over.


* * * * * *

Services

The Viridis Group provides several primary services:

  • Finding "best-fit" outsourcing vendors. Identification, assessment, and retention of ideal R&D facilitators (e.g., CROs, SMOs, clinical labs, regulatory consultants, monitors) for each project. We maintain a constantly-updated database of vendors’ capabilities, capacities, specialty services, and interests - and match them to your needs.
  • Facilitating academicians’ research efforts. Assisting both basic ("bench") scientists and clinical investigators in the commercialization of their discoveries and their transfer to the private sector. We work closely with the academic investigators, their staffs and their universities’ research management offices.
  • Evaluating Internet-based R&D facilitation systems. Assessing the latest web-based tools such as data capture, project management, biostatistical analysis and budget tracking. Special attention paid to long-term logistical and cost advantages of implementing E-technologies.
  • Identifying sources of R&D financing. Venture capital, industry-sponsored grants, IPOs, mezzanine financing, SBA grants, others funding resources.
  • Assisting in strategic planning. Business plan formulation/evaluation, strategic and tactical ("critical path") management, staffing/cost issues (in-house research conduct vs outsourcing), partnering with other development firms, equity valuation/use.
  • Expediting firms’ intellectual property. Patents, licensing, intellectual property valuation and technology transfer of biomedical discoveries.


Professional Fees

The Viridis Group charges reasonable and customary consulting fees, at rates far below those of large management consulting firms. Upon contracting, a traditional retainer fee is payable, against which the first twenty (20) billable hours are charged. Other fees and charges, as well as a comprehensive description of services, will be covered during a personal presentation.

 
The Viridis Group, LLC
28 Douglas Road
Norwich, VT 05055
Phone: 802.649.2098
Fax: 802.649.2094
info@viridisgroup.com